These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11030639)

  • 21. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up.
    Storr M; Allescher HD; Rösch T; Born P; Weigert N; Classen M
    Gastrointest Endosc; 2001 Dec; 54(6):754-9. PubMed ID: 11726856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early experience with intrasphincteric botulinum toxin in the treatment of achalasia.
    Greaves RR; Mulcahy HE; Patchett SE; Gorard DA; Fairclough PD; Alstead EM; Farthing MJ
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1221-5. PubMed ID: 10468705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders.
    Vanuytsel T; Bisschops R; Farré R; Pauwels A; Holvoet L; Arts J; Caenepeel P; De Wulf D; Mimidis K; Rommel N; Tack J
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1115-1121.e2. PubMed ID: 23591282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: a pilot trial.
    Wehrmann T; Schmitt T; Dietrich CF; Caspary WF; Seifert H
    Z Gastroenterol; 2000 Nov; 38(11):899-903. PubMed ID: 11132536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin.
    Brisinda G; Civello IM; Albanese A; Maria G
    Curr Med Chem; 2003 Apr; 10(7):603-23. PubMed ID: 12678792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
    Katzka DA; Castell DO
    Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin for spastic GI disorders: a systematic review.
    Zhao X; Pasricha PJ
    Gastrointest Endosc; 2003 Feb; 57(2):219-35. PubMed ID: 12556788
    [No Abstract]   [Full Text] [Related]  

  • 28. Current trends in the management of achalasia.
    Bruley des Varannes S; Scarpignato C
    Dig Liver Dis; 2001 Apr; 33(3):266-77. PubMed ID: 11407673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Botulinum toxin injection in the management of achalasia.
    Ramzan Z; Nassri AB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intrasphincteric injection of botulinum toxin in patients with esophageal achalasia].
    Zapata R; Carvajal S; Alvarez M; González R; Chianale J; Rollán A
    Rev Med Chil; 1997 Aug; 125(8):899-904. PubMed ID: 9567393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter.
    Rees CJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Dec; 15(6):409-11. PubMed ID: 17986880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin: indications in internal medicine].
    Allescher HD; Storr M
    Internist (Berl); 2002 Dec; 43(12):1566-74. PubMed ID: 12607396
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin for achalasia in children.
    Ip KS; Cameron DJ; Catto-Smith AG; Hardikar W
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1100-4. PubMed ID: 11106087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin in clinical practice.
    Jankovic J
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):951-7. PubMed ID: 15201348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?
    Lacy BE; Weiser K; Kennedy A
    Gastroenterol Hepatol (N Y); 2008 Apr; 4(4):283-95. PubMed ID: 21960915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain.
    Murray W; Kong S
    Scand J Gastroenterol; 2010 May; 45(5):623-7. PubMed ID: 20156033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum Toxin A Use in the Gastrointestinal Tract: A Reappraisal After Three Decades.
    Mohajir WA; Khurana S; Singh K; Chong RW; Bhutani MS
    Gastroenterol Hepatol (N Y); 2023 Apr; 19(4):198-212. PubMed ID: 37705841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
    Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
    Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.